Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Bedossa

Showing results (101-110 of 267) with videos related to

Pageof 27
Sort By:
Annals of Hepatology|October 6, 2015
Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis BAna C Cardoso, Michel Beaugrand, Victor de Ledinghen, et al.
BMJ Open Gastroenterology|April 26, 2016
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver diseaseFabio Nascimbeni, Judith Aron-Wisnewsky, Raluca Pais, et al.
Virology|January 22, 2005
Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infectionIvan Bièche, Tarik Asselah, Ingrid Laurendeau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2008
Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factorsFirouzé Bani-Sadr, Nathanael Lapidus, Pierre Bedossa, et al.
Hepatology (Baltimore, Md.)|July 31, 2007
Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective studyPierre Bedossa, Rami Moucari, Emna Chelbi, et al.
Human Pathology|September 26, 2006
Direct and indirect evidence for the reversibility of cirrhosisJeanne Serpaggi, Françoise Carnot, Bertrand Nalpas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 14, 2015
TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinomaAmedeo Sciarra, Maxime Ronot, Luca Di Tommaso, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2023
Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysisThierry Poynard, Olivier Deckmyn, Valentina Peta, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 22, 2011
Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapySarah Maylin, Cédric Laouénan, Michelle Martinot-Peignoux, et al.
Fundamental & Clinical Pharmacology|January 6, 2004
Inhibitors of swelling-activated chloride channels increase infarct size and apoptosis in rabbit myocardiumRachid Souktani, Bijan Ghaleh, Renaud Tissier, et al.
Pageof 27

Showing results (101-110 of 267) with videos related to

Sort By:
Pageof 27
Annals of Hepatology|October 6, 2015
Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis BAna C Cardoso, Michel Beaugrand, Victor de Ledinghen, et al.
BMJ Open Gastroenterology|April 26, 2016
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver diseaseFabio Nascimbeni, Judith Aron-Wisnewsky, Raluca Pais, et al.
Virology|January 22, 2005
Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infectionIvan Bièche, Tarik Asselah, Ingrid Laurendeau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2008
Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factorsFirouzé Bani-Sadr, Nathanael Lapidus, Pierre Bedossa, et al.
Hepatology (Baltimore, Md.)|July 31, 2007
Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective studyPierre Bedossa, Rami Moucari, Emna Chelbi, et al.
Human Pathology|September 26, 2006
Direct and indirect evidence for the reversibility of cirrhosisJeanne Serpaggi, Françoise Carnot, Bertrand Nalpas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 14, 2015
TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinomaAmedeo Sciarra, Maxime Ronot, Luca Di Tommaso, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2023
Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysisThierry Poynard, Olivier Deckmyn, Valentina Peta, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 22, 2011
Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapySarah Maylin, Cédric Laouénan, Michelle Martinot-Peignoux, et al.
Fundamental & Clinical Pharmacology|January 6, 2004
Inhibitors of swelling-activated chloride channels increase infarct size and apoptosis in rabbit myocardiumRachid Souktani, Bijan Ghaleh, Renaud Tissier, et al.
Pageof 27